Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-6 of 6

Sort by

Sort Order Select

Journal Articles

eIF4E Activation Is Commonly Elevated in Advanced Human Prostate Cancers and Significantly Related to Reduced Patient Survival

Jeremy R. Graff, Bruce W. Konicek, Rebecca L. Lynch, Chad A. Dumstorf, Michele S. Dowless, Ann M. McNulty, Stephen H. Parsons, Leslie H. Brail, Bruce M. Colligan, Jonathan W. Koop, Bernadette M. Hurst, James A. Deddens, Blake L. Neubauer, Louis F. Stancato, Harry W. Carter, Larry E. Douglass, Julia H. Carter

Cancer Res (2009) 69 (9): 3866–3873.

https://doi.org/10.1158/0008-5472.CAN-08-3472

Published: 30 April 2009

View article titled, eIF4E Activation Is Commonly Elevated in Advanced Human Prostate Cancers and Significantly Related to Reduced Patient Survival

Includes: Supplementary data

Journal Articles

Enzastaurin (LY317615.HCl) suppresses signaling through the PKC and AKT pathways, inducing apoptosis, suppressing tumor-induced angiogenesis and reducing growth of human cancer xenografts

Ann M. McNulty, Bruce W. Konicek, Rebecca L. Lynch, Donald Thornton, Larry Douglass, Bruce Colligan, Julia H. Carter, Jeremy R. Graff

Cancer Res (2006) 66 (8_Supplement): 314–315.

Published: 15 April 2006

View article titled, Enzastaurin (LY317615.HCl) suppresses signaling through the PKC and AKT pathways, inducing apoptosis, suppressing tumor-induced angiogenesis and reducing growth of human cancer xenografts

Journal Articles

The Protein Kinase Cβ–Selective Inhibitor, Enzastaurin (LY317615.HCl), Suppresses Signaling through the AKT Pathway, Induces Apoptosis, and Suppresses Growth of Human Colon Cancer and Glioblastoma Xenografts

Jeremy R. Graff, Ann M. McNulty, Kimberly Ross Hanna, Bruce W. Konicek, Rebecca L. Lynch, Spring N. Bailey, Crystal Banks, Andrew Capen, Robin Goode, Jason E. Lewis, Lillian Sams, Karen L. Huss, Robert M. Campbell, Philip W. Iversen, Blake Lee Neubauer, Thomas J. Brown, Luna Musib, Sandaruwan Geeganage, Donald Thornton

Cancer Res (2005) 65 (16): 7462–7469.

https://doi.org/10.1158/0008-5472.CAN-05-0071

Published: 15 August 2005

View article titled, The Protein Kinase Cβ–Selective Inhibitor, Enzastaurin (LY317615.HCl), Suppresses Signaling through the AKT Pathway, Induces Apoptosis, and Suppresses Growth of Human Colon Cancer and Glioblastoma Xenografts

Journal Articles

Depleting eIF4E expression with a novel eIF4E targeted antisense oligonucleotide suppresses eIF4E expression and human xenograft tumor growth without overt toxicity

Jeremy R. Graff, Bruce W. Konicek, Rebecca L. Lynch, Thomas M. Vincent, Spring N. Bailey, Phil Schwier, Drew Capen, Robin Goode, Sean Sissons, Karen Cox, Ann M. McNulty, Tao Wang, Lillian Sams, Sandaruwan Geeganage, Larry E. Douglass, Julia H. Carter, Eric G. Marcusson

Cancer Res (2005) 65 (9_Supplement): 135–136.

Published: 01 May 2005

View article titled, Depleting eIF4E expression with a novel eIF4E targeted antisense oligonucleotide suppresses eIF4E expression and human xenograft tumor growth without overt toxicity

Journal Articles

Enzastaurin HCl (LY317615) suppresses GSK3β phosphorylation, induces apoptosis and suppresses growth of human colon cancer and glioblastoma xenografts

Jeremy R. Graff, Ann M. McNulty, Kimberly R. Hanna, Bruce W. Konicek, Rebecca L. Lynch, Spring N. Bailey, Crystal Banks, Drew Capen, Robin L. Goode, Jason E. Lewis, Lillian Sams, Blake L. Neubauer, Sandaruwan Geeganage, Don Thornton

Cancer Res (2005) 65 (9_Supplement): 157–158.

Published: 01 May 2005

View article titled, Enzastaurin HCl (LY317615) suppresses GSK3β phosphorylation, induces apoptosis and suppresses growth of human colon cancer and glioblastoma xenografts

Journal Articles

Eukaryotic translation initiation factor eIF-4E is consistently upregulated with human prostate cancer progression: Inhibition by siRNA or ASO therapy suppresses CaP xenograft growth.

Jeremy R. Graff, Bruce W. Konicek, Rebecca L. Lynch, Kimberly R. Hanna, Spring N. Bailey, Robin L. Goode, Ann M. McNulty, Mac A. Johnson, Blake L. Neubauer, Harry C. Carter, Thomas Vincent, Eric Marcusson, Bruce Colligan, Larry E. Douglass, Julia H. Carter

Cancer Res (2004) 64 (7_Supplement): 835–836.

Published: 01 April 2004

View article titled, Eukaryotic translation initiation factor eIF-4E is consistently upregulated with human prostate cancer progression: Inhibition by siRNA or ASO therapy suppresses CaP xenograft growth.

NARROW

eIF4E Activation Is Commonly Elevated in Advanced Human Prostate Cancers and Significantly Related to Reduced Patient Survival

Enzastaurin (LY317615.HCl) suppresses signaling through the PKC and AKT pathways, inducing apoptosis, suppressing tumor-induced angiogenesis and reducing growth of human cancer xenografts

The Protein Kinase Cβ–Selective Inhibitor, Enzastaurin (LY317615.HCl), Suppresses Signaling through the AKT Pathway, Induces Apoptosis, and Suppresses Growth of Human Colon Cancer and Glioblastoma Xenografts

Depleting eIF4E expression with a novel eIF4E targeted antisense oligonucleotide suppresses eIF4E expression and human xenograft tumor growth without overt toxicity

Enzastaurin HCl (LY317615) suppresses GSK3β phosphorylation, induces apoptosis and suppresses growth of human colon cancer and glioblastoma xenografts

Eukaryotic translation initiation factor eIF-4E is consistently upregulated with human prostate cancer progression: Inhibition by siRNA or ASO therapy suppresses CaP xenograft growth.

Email alerts

AACR Journals

eIF4E Activation Is Commonly Elevated in Advanced Human Prostate Cancers and Significantly Related to Reduced Patient Survival

Enzastaurin (LY317615.HCl) suppresses signaling through the PKC and AKT pathways, inducing apoptosis, suppressing tumor-induced angiogenesis and reducing growth of human cancer xenografts

The Protein Kinase Cβ–Selective Inhibitor, Enzastaurin (LY317615.HCl), Suppresses Signaling through the AKT Pathway, Induces Apoptosis, and Suppresses Growth of Human Colon Cancer and Glioblastoma Xenografts

Depleting eIF4E expression with a novel eIF4E targeted antisense oligonucleotide suppresses eIF4E expression and human xenograft tumor growth without overt toxicity

Enzastaurin HCl (LY317615) suppresses GSK3β phosphorylation, induces apoptosis and suppresses growth of human colon cancer and glioblastoma xenografts

Eukaryotic translation initiation factor eIF-4E is consistently upregulated with human prostate cancer progression: Inhibition by siRNA or ASO therapy suppresses CaP xenograft growth.

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only